Purchase Order 75N94019P00469
Award Date 6/5/19
Potential Completion Date 6/22/20
Potential Value $34K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Service Contract Act
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $223,892.08 firm fixed price purchase order to Illumina, Inc. for a service contract to maintain the operation of Illumina HiSeq 3000 and cBOT DNA sequencing instruments. This non-competitive, brand-name contract was awarded under simplified acquisition procedures, as Illumina is the sole manufacturer and authorized provider of maintenance services for these instruments. The...
- This is a firm fixed-price purchase order contract awarded by the National Institutes of Health (NIH) Clinical Center to Illumina, Inc., a manufacturer of genetic sequencing systems and related products. The contract provides for a HISEQ 2500 Silver Support Plan, with an ultimate completion date of April 28, 2022, and a ceiling value of $96,921.00. Illumina has previously held prime federal contracts and sub-grants with various civilian agencies to supply sequencing instruments, reagents, and...
- This is a firm fixed price delivery order contract awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency, to Illumina, Inc., a for-profit manufacturer of genomic sequencing and analysis products. The contract has a ceiling value of $100,502.64 and a completion date of September 2, 2020. Illumina has provided various sequencing systems, reagents, consumables, and bioinformatics products to support genomic research and diagnostics for NIDDK...
- This is a firm fixed-price purchase order contract awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency within the Department of Health and Human Services (HHS), to Illumina, Inc. The contract, valued at $72,422.58, is for the provision of Illumina's sequencing instruments, reagents, and related products and services to support NIDDK's genomic research and analysis needs. Illumina has previously served as a prime contractor and...
- This is a firm fixed price purchase order awarded by the National Human Genome Research Institute, a civilian agency, to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The contract, valued at $159,964.64, is for a Comprehensive Service Contract to provide Silver Support services. There is no set-aside designation for this award. Based on Illumina's prior work with federal agencies like the NIH, CDC, USDA, and VA, the services provided under this...
- This is a firm fixed price service contract awarded by the Department of Health and Human Services National Institutes of Health Office of Logistics and Acquisition Operations to Illumina, Inc., a manufacturer of genomic sequencing instruments and reagents. The contract, valued at $411,137.00, provides for the renewal and maintenance of an Illumina HiSeq2500 sequencing system. The contract has no set-aside designation and was awarded on June 7, 2017, with a completion date of December 10,...
- The Department of Health and Human Services National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases awarded a $201,059.24 firm fixed price purchase order to Illumina, Inc., a for-profit manufacturer of genomics analysis instruments and reagents, for an annual NextSeq 550 sequencing instrument service plan. The contract has a base year from April 30, 2022 to April 29, 2023 with four one-year option periods. Illumina is the sole authorized service provider...
- This is a firm fixed price purchase order contract awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency under the Department of Health and Human Services, to Illumina, Inc. The contract, valued at $80,449.94, is for the provision of Illumina's sequencing and analytical instruments and reagents to support NIDDK's genomic research and diagnostics efforts. The contract has no set-aside designation. Illumina has previously been awarded prime...
- This is a firm fixed price federal contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Illumina, Inc. to provide the HiSeq 2500 sequencing system to the NHLBI Division of Intramural Research (DIR). The contract has a ceiling value of $647,403.80 and a period of performance ending on March 24, 2015. There is no set-aside designation associated with this award. Illumina, Inc. is a manufacturer and provider of...
- This is a firm fixed price delivery order contract awarded by the National Institutes of Health (NIH) to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The contract has a ceiling value of $16,648.41 and a performance period extending through June 8, 2025. Illumina will provide a range of genomic sequencing platforms, reagents, consumables, maintenance services, and technical support to the NIH. This includes the procurement of NextSeq, NovaSeq,...